AI-generated summary
The authors reviewed 15 clinical studies of a dual 1550-nm and 1927-nm fractional laser system in people with darker skin (Fitzpatrick types III to VI). They report consistent improvement in scarring and melasma with the 1550-nm wavelength and in melasma and photoaging with the 1927-nm wavelength. Postinflammatory hyperpigmentation rates varied across studies, and lower energy or density was associated with fewer of these effects. The authors note that more studies are needed, particularly for patients with type VI skin and the 1927-nm wavelength.
- Studies included
- 15
- Who or what was studied
- Patients with skin of color (Fitzpatrick skin types III to VI)
- Wavelengths
- 1550, 1927 nm
- Limits stated in the abstract
- Study designs varied considerably, and the authors state that additional studies are needed, particularly for Fitzpatrick type VI and the 1927-nm wavelength.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.